News

Small caps round-up: Mediwatch, Amarin, Chagala

18 January 2008 09:20:00

Medical diagnostic firm Mediwatch said it noted the recent increase in its share price and confirmed it had received an approach.

The group said it is in discussions that may or may not lead to an offer being made for the company.

Drug developer Amarin said its shareholders had approved a one for 10 reverse split of its ordinary shares.

"We are very pleased to report that over 95% of the votes cast by our shareholders
approved the one-for-ten reverse stock split," chairman and chief executive Thomas Lynch said.

"We have made good progress in recent months expanding our management team and broadening our pipeline and look forward to executing on our strategy which we believe will drive shareholder value in 2008."

Kazakh real estate developer Chagala Group has appointed Peter Lourenco as chief executive officer of Chagala Zere Malls, its joint venture with Kazakh developer Zere.

Chagala holds a 50.1% stake in the joint venture, which was established to develop shopping malls across Kazakhstan.

Web hosting firm Group NBT said the good start at the time of the AGM has continued throughout the first half of the year and it expects to report continuing strong growth.

i-design said it expects to see a significant increase in advertising sales revenue this year, driven by its third party advertising agreements with RBS, Alliance & Leicester and Nationwide.

"We continue to see good growth opportunities, both in the UK and overseas, and view prospects for the current year and beyond very positively," said chairman James Faulds.

Advanced fuel cell solutions group IdaTech said trading for 2007 was in line with expectations, adding that it is confident in achieving its objectives for 2008.

All data suppied by Digital Look (15 minute delay)




Risk Warning

There is an extra risk of losing money when shares are bought in some smaller companies including 'Penny Shares'. There is a big difference between the buying price and the selling price of these shares. If they have to be sold immediately, you may get back much less than you paid for them or you may have difficulty in selling them. Past performance is not a reliable indicator of future results. The price may change quickly and it may go down as well as up. You could lose every penny put into a particular share.

The information contained above has been compiled from documented sources which are believed to be reliable but, due to their very nature, are subject to a degree of historical inaccuracy and have not been independently verified and cannot be guaranteed. The pages on this website are provided for information only. City Equities Limited will not accept responsibility for loss incurred by any person or body acting, or refraining from acting, as a result of information and/or opinions given anywhere on this website. Issued by City Equities Limited, Aldermary House, 10-15 Queen Street, London, EC4N 1TY. Registered in England. Registered No. 2742847. Registered Address: Amwell House, 19 Amwell Street, Hoddeson, Herts. EN11 8TS. City Equities Limited is Authorised and regulated by the Financial Services Authority. Registration No. 155051.